Results:

1. diureticos en el sindrome nefrotico
in animal studies, warfarin and sulfisoxazole, which act as inhibitors of protein binding, restored the potency of furosemide in nephrotic syndrome. whether there is a role for protein binding inhibitors in the treatment of patients ...

2. i love my lithium!
lithium has negligible protein binding and is distributed throughout the body, with slightly greater concentrations in thyroid, bone, and brain tissue. it is excreted unchanged in urine. a 300 mg dose of lithium carbonate tablets ...

3. DRUGS --D
Mechanism of Action: Inhibition of insulin release, arteriolar vasodilatation and decreased peripheral resistance. Absorption/Distribution: Rapidly absorbed; high protein binding. Half life: 20–{endash}36 h ...

4. DRUGS site,more download
Absorption/Distribution: High protein binding. Half life: 3 w. IM: 3–{endash}9 d. Metabolism: Hepatic. Elimination: Renal/biliary. Research Notes: Decanoate form acts as a prodrug, slowly releasing haloperidol into system ...

5. DRUGS--E & F
Unaccepted Indications: Rheumatoid arthritis. Mechanism of Action: Inhibits the synthesis of prostaglandins. Absorption/Distribution: Rapidly absorbed; extensively distributed; very high protein binding. Half life: Approximately 1 h ...

6. DRUGS with Trade name--C
Absorption/Distribution: 33% absorbed in the small intestine; moderate protein binding. Elimination: Fecal, renal. Research Notes: Contains equivalent of 400 mg of calcium ion/g. Adult Dosage: 1.5 g once daily to tid ...

7. anesthesia march' 08
b. dec plasma protein binding 5. enzyme induction occurs in: a. liver b. kidney c. heart d. adrenals 6. digoxin toxicity a. inc k* b. inc mg* c. dec ca** d. dec na* e. alkalosis 7. secondary active transport occurs thru a. glucose ...

8. amikacin
protein-binding: 0% to 11% half-life elimination (renal function and age dependent): infants: low birth weight (1-3 days): 7-9 hours; full-term >7 days: 4-5 hours children: 1.6-2.5 hours adults: normal renal function: 1.4-2.3 hours; ...

9. Amiodarone
Protein binding: 96% Metabolism: Hepatic via CYP2C8 and 3A4 to active N-desethylamiodarone metabolite; possible enterohepatic recirculation Bioavailability: Oral: ~50% Half-life elimination: Terminal: 40-55 days (range: 26-107 days); ...

10. sindroma nefrotik
fibrinogen and albumin metabolism in nephritic patients. kidney int 2001; 60 (1): 235-42. agarwal r, gorski jc, sundblad k, brater dc. urinary protein binding does not affect response to furosemide in patients with nephrotic syndrome. ...